Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease squamous cell carcinoma of esophagus
Comorbidity C0007137|squamous cell carcinoma
Sentences 24
PubMedID- 21603589 In squamous cell carcinoma of the esophagus, oct-4 expression is highly elevated in the sp population compared to non-sp cells [47].
PubMedID- 24281163 squamous cell carcinoma of the esophagus remains predominantly a disease of the developing world.
PubMedID- 21888637 Patients with metastatic or recurrent squamous cell carcinoma of the esophagus that had been histologically confirmed were eligible.
PubMedID- 21810561 However, in squamous cell carcinoma of the esophagus the survival advantage was only observed in the neoadjuvant concurrent chemoradiation therapy.
PubMedID- 24633395 A 2011 study showed a positive association between red meat intake and squamous cell carcinoma of the esophagus [45].
PubMedID- 22934214 However, there is no case report about ee-associated superficial squamous cell carcinoma of the esophagus in english literature.
PubMedID- 23234272 This study was designed to use the taiwan national health insurance claims data to evaluate whether the squamous cell carcinoma of the esophagus is associated with dm.
PubMedID- 23878488 Biopsy from esophagus revealed poorly differentiated squamous cell carcinoma of the esophagus [figure 3].
PubMedID- PMC4317881 In their exciting work, uraoka and colleagues analyzed tissue samples from patients with squamous cell carcinoma of the esophagus for gene expression that could predict outcomes.
PubMedID- PMC4595409 The lymph nodes from the left axilla contained metastatic cells from the squamous cell carcinoma of the esophagus.
PubMedID- 26468007 Patients with recurrent or metastatic squamous cell carcinoma of the esophagus who had not previously been treated palliative chemotherapy for metastatic disease were eligible.
PubMedID- 22133387 Underlying malignancies were colorectal cancer (five studies), non-small cell lung cancer (four studies), pancreatic cancer (two studies), head and neck cancer (two studies), and squamous cell carcinoma of the esophagus (one study).
PubMedID- 25609176 Patients who had undergone esd to treat histologically confirmed early squamous cell carcinoma of the esophagus from february 2010 to october 2011 and who were expected to have a mucosal defect encompassing ≥75% of the circumference of the esophageal mucosa after esd were eligible for the study.
PubMedID- 25861290 In squamous cell carcinoma of the esophagus, the exact role played by regulating growth factors still remains unknown.
PubMedID- 20070914 Id expression is deregulated in many tumors, including cervical cancer [9], melanoma [10], pancreatic cancer [11], squamous cell carcinoma of the esophagus [12] and in thyroid cancer [13].
PubMedID- PMC4070603 Achalasia seems to be a risk factor for developing squamous cell carcinoma of the esophagus, even if after surgically treated.
PubMedID- 24369500 All patients included in this study had histologically diagnosed squamous cell carcinoma of the esophagus and underwent barium esophagography before and after nacrt.
PubMedID- 22809481 Ezh2 has been detected in tumors with various origins, such as urothelial carcinoma, squamous cell carcinoma of the esophagus, gastric cancer, glioma, renal cell carcinoma, non-small cell lung carcinoma (nsclc), colorectal carcinoma and breast cancer [14-21].
PubMedID- 22590529 High epcam expression was associated with poor survival rates for breast, gall bladder and squamous cell carcinoma of the esophagus whereas better survival rates were reported for renal cell carcinoma and pancreatic cancer [8], [9], [10], [11], [12].
PubMedID- 26135259 Individual studies suggest that male gender, presentation with alarm symptoms, endoscopists with less experience, pathology errors, failure to biopsy lesions adequately, follow-up errors, and squamous cell carcinoma of the esophagus may all be important factors in the failure to detect cancer at ugi endoscopy.
PubMedID- 24636138 Subsequently, many studies have shown that smad4 is underexpressed in various human tumors, including stomach cancer, squamous cell carcinoma of the esophagus, and breast cancer, and smad4 has been proposed as a prognostic marker for tumor formation and progression[18,31,32].
PubMedID- 24348048 Rrm2b has been shown to suppress invasion and metastasis in colorectal cancer, and its expression is associated with a better survival prognosis in patients with colorectal cancer.29 however, in squamous cell carcinoma of the esophagus, rrm2b expression was significantly correlated with depth of invasion, lymph node metastasis, stage, and poor prognosis.30 accordingly, these findings reveal that subunit expression of rr is closely associated with tumor progression, invasion, and metastasis.
PubMedID- 21254737 Multiple genetic modifications have been determined in squamous cell carcinoma of the esophagus [12](table 3).
PubMedID- 24346922 We report a case with exuberant clinical manifestations,exemplifying the typical cutaneous lesions in this rare syndrome, in a patient withsquamous cell carcinoma of the esophagus.

Page: 1